Astellas Pharma (Japan)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
53%
Total
Publications
4.9K
Total Open
Publications
2.6K
Total
Citations
138K
Open Access
Percentage
53%
Total
Publications
4.9K
Total Open
Publications
2.6K
Total
Citations
138K
Breakdown
Publisher Open
25%
Both
22%
Other Platform Open
6%
Closed
47%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 24%
559
Hybrid 45%
1K
No Guarantees 31%
732
Other Platform Open
Domain 85%
1.1K
Institution 18%
249
Public 11%
148
Other Internet 8%
107
Preprint 4%
51
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.1K |
Europe PMC | Domain | 597 |
Semantic Scholar | Public | 118 |
DOI | Other Internet | 102 |
Figshare | Public | 67 |
University College London - UCL Discovery | Institution | 25 |
Research Square | Preprint | 25 |
California Digital Library - eScholarship | Other Internet | 24 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 23 |
Taylor and Francis Group - Dove Medical Press | Other Internet | 21 |